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Introduction: The Inter RAI Minimal Data Set for Acute Care (MDS-AC) is a geriatric assessment tool 
designed for use in acute medicine care. We used data from a study on the MDS-AC to evaluate the medica-
tion use of 75+ year old patients (n=730) admitted to selected acute care hospitals in five Nordic countries. 
Associations of medication use with: Preadmission Activities of Daily Living (ADL), Instrumental Activi-
ties of Daily Living (IADL), Cognitive Performance Scale (CPS) , walking, memory, continence, falls, 
chronic pain, admission delirium, length of stay in hospital (LOS) and 12 months survival after discharge, 
were analyzed. Special focus was on polyphamacy, inappropriate medications, psychotropic medication use 
and cardiovascular medications. 
Results: Average number of drugs was 6.2(SD+/-3.7). Polypharmacy (five or more medications) was found 
among 66% of patients and 16% used inappropriate medications. Women used on average more medications 
than men, 6.6 vs 5.7 respectively (p < .05). Polypharmacy was associated with worse IADL function and 
pain (p<.001) and better cognitive function and less falls (p < .05). Inappropriate medications were associat-
ed to increased length of stay (p<.05). Psychotropic medications had the most pronounced association with 
worse function and outcomes in a variety of variables. Cardiovascular drugs were associated with better 
functional outcome.
Conclusion: Polypharmacy, use of inappropriate medications and psychotropic medication use were preva-
lent in this study. Associations were found between these factors and negative functional outcomes. Individ-
ual tailoring of pharmacotherapy of acutely ill older patients with concomitant chronic illnesses combined 
with functional impairment is important.
Key words: Medications, elderly patients, acute care, polypharmacy, inappropriate medications, MDS-AC, 
Inter RAI
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Introduction 
Polypharmacy, disease burden and age related physiological 
changes contribute to making older individuals susceptible 
to Adverse Drug Reactions (ADRs).(1) Frail older people are 
known to be at greater risk of ADRs compared with their 
healthier peers. (2,3) With increasing availability of medica-
tions for various ailments, so has polypharmacy (here defined 
as five or more medications) increased among older people 
during the last decades. (5,6) Polypharmacy contributes to 
poor compliance and increased risk for drug-drug and drug-
disease interactions, especially among the most frail. (7,8,9,10) 
Because older people are especially vulnerable to negative 
effects of certain types of drugs several medications have been 
defined as potentially inappropriate for older people.(11,12) 
Examples include benzodiazepines with long half life and 
drugs with high anticholinergic effects causing, among other 
concerns, increased risk for falls, delirium and orthostatic hy-
potension(13,14,15). The frequency of inappropriate prescrib-
ing among hospitalized older patients has in some studies been 
shown to be between 32-50% (16,17).
Psychotropic medications are the most prevalent among drugs 
considered inappropriate for older people, constituting about 
50% of such defined drugs. (18) Cardiovascular drug use is 
very prevalent among older persons and a common cause of 
ADRs . While the benefit of these medications is often well 
documented on correct indications they should be used under 
good supervision and frequently reviewed among older per-
sons. (19,20,21,22) 
When treating older patients it is appropriate to individual-
ize the approach. This requires a comprehensive evaluation 
of the patient and his/her environment and collecting infor-
mation on cognitive and physical function. The benefits of 
a comprehensive geriatric evaluation has been studied both 
among hospitalized and community living older people. The 
usefulness of such an evaluation in relation to medications 
lies in a clearer view of an often complicated patient and can 
be a useful tool for follow up, measuring both positive and 
negative effects associated with change in treatment. Several 
different tools for geriatric evaluation have been developed. In 
this study we used the Inter RAI Minimal Data Set for Acute 
Care (MDS-AC). The MDS-AC instrument is used to register 
key information regarding social and functional aspects and 
comorbidity and is designed for use in the acute medicine care 
setting.(23,24,25) 
The aim of this study was to analyze drug treatment of older 
acute care patients and its association with functional capac-
ity and outcomes such as length of stay and one year survival. 
Special emphasis was on polypharmacy, inappropriate medi-




A member of the Inter RAI (Resident Assessment Instrument) 
family, the Minimal Data Set for Acute Care (MDS-AC) is a 
standardized Inter-RAI instrument for comprehensive geriatic 
evaluation. It is specially designed for use in acute medicine 
care. The MDS-AC covers 14 key areas with 56 standardized 
variables conserning demographics, activities of daily living 
(ADL), instrumental activities of daily living (IADL), cogni-
tive perfomance scale (CPS), pain, history of falls, nutrition, 
continence and more.(23) Information on medication use was 
collected at admission. At admission premorbid informa-
tion on functional status one month prior to current illness 
was registered. For this study we used admission data on 
medication use and premorbid data for function to minimize 
the confounding effect of current acute illness on functional 
parameters. 
Participants
The main original objective of the MDS-AC Nordic study was 
to test the MDS-AC instrument in the acute medical care set-
ting.(24,25) Analyses of the drug data and possible effects of 
medication use on function adds information on the reliability 
and useability of MDS-AC. 
 
The MDS-AC study was performed in one acute care hospi-
tal in each of the five Nordic countries, Denmark, Norway, 
Sweden, Finland and Iceland, between January 2001 and April 
2002. Each study hospital had an uptake area of about 90,000 
people and admitted patients for all internal medicine special-
ties. In each country, participants had to be 75 years of age 
or older and were randomly selected from the previous day 
admission lists. Excluded were patients who were admitted 
for less than 24 hours, those who needed intensive care and 
patients transferred from other hospitals. 
Each study participant was evaluated in the first 24 hours after 
admission, admission drugs were registered and information 
on function one month before current admission and admis-
sion status was collected. Information on mortality and place 
of residence was collected 12 months later. Length of stay 
in hospital was registered. The evaluation was performed by 
nurses or doctors trained in the use of the MDS-AC instru-
ment. In all, 770 patients were included in the study and suf-
ficient information on medication use was registered for 730 
participants (Table 1 - next page). 
 
Medication use was analysed in relation to sex, age and coun-
tries but main emphasis was on looking at medications for the 
group as a whole. Focus was on polypharmacy, inappropri-
ate medications, psychotropic and cardiovascular medica-
tions. Polypharmacy was defined as use of 5 or more drugs 
(excluding vitamins and calcium). Psychotropic medications 
were considered the following ATC (Anatomical Therapeutic 
chemical Classification) categories; antidepressants (N06A) , 
hypnotics and sedatives (N05C), anxiolytics (N05B) and an-
tipsychotics (N05A). In our analyses we sometimes combined 
hypnotics, sedatives and anxiolytics as it was often difficult to 
know for which indication they were used. Benzodiazepines 
were looked at separately when estimating the association 
of medication use and outcome variables from the MDS-AC 
instrument. 
Cardiovascular drugs were considered ATC group C. For 
evaluation of an association with functional and outcome vari-
ables statins (C10AA), beta blockers (C07), calcium channel 
blockers(C08), diuretics (C03), angiotensin converting enzyme
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Table 1. Characteristics and outcomes of elderly patients admitted to acute care 
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*p <.05 more use among women, **p <.001 less use among >90 olds
Table 2: Type of medication used among elderly patients at admission according sex and and age 
Medication use was analysed in relation to sex, age and coun-
tries but main emphasis was on looking at medications for the 
group as a whole. Focus was on polypharmacy, inappropri-
ate medications, psychotropic and cardiovascular medica-
tions. Polypharmacy was defined as use of 5 or more drugs 
(excluding vitamins and calcium). Psychotropic medications 
were considered the following ATC (Anatomical Therapeutic 
chemical Classification) categories; antidepressants (N06A) , 
hypnotics and sedatives (N05C), anxiolytics (N05B) and an-
tipsychotics (N05A). In our analyses we sometimes combined 
hypnotics, sedatives and anxiolytics as it was often difficult to 
know for which indication they were used. Benzodiazepines 
were looked at separately when estimating the association 
of medication use and outcome variables from the MDS-AC 
instrument. 
Cardiovascular drugs were considered ATC group C. For 
evaluation of an association with functional and outcome vari-
ables statins (C10AA), beta blockers (C07), calcium channel 
blockers(C08), diuretics (C03), angiotensin converting enzyme 
inhibitors (ACEi) (C09A and B) and angiotensin receptor 
blockers (ARBs) (C09C and D) were looked at separately. 
 
Potentially inappropriate medications were defined as the 
quality indicator on drug treatment used by the Swedish health 
authorities which includes (independent of dosage or diag-
noses): a) drugs with high anticholinergic activity, b) benzodi-
azepines with long elimination half life, c) cimetidine, d) theo-
phyllamine, e) quinine26. These drugs are grouped together so 
that having one or more of these medications counts as using a 
potentially inappropriate medication.
Drug treatment was assessed with regards to Activities of 
Daily Living Hierarchy (ADL, 0-6), Instrumental Activities 
of Daily Living (IADL, 0-21), Cognitive performance Scale 
(CPS,0-6), walking ( 0-4), memory (0 =intact, 1=impaired), 
continence (0-4), falls, chronic pain (0-3), admission delirium, 
length of stay in hospital (LOS) and survival 12 months after 
admission. For all the variables a higher number on a scale 
stands for worse function or a higher frequency of an event.
Statistical analysis
Data were analyzed using SPSS software version 11. Sig-
nificance of association between categorical variables was 
assessed using Chi-square test. Assessment of mean dif-
ference between the two groups was made using t-test, and 
between more than two groups by using Anova. Following 
the Anova, Tukey was used as the post-hoc test for individual 
pairs of means. Multiple linear regression was used to assess 
the associations between drug treatment functional variables 
and chosen outcomes . The multiple linear regression analy-
ses included the following variables: number of drugs, use of 
inappropriate medication, psychotropic drugs and cardiovas-
cular drugs. The association between medical treatment and 
functional capacity or length of stay was also assessed using 
Spearman s´ rho correlation or Mann-Whitney test, depend-
ing on whether the independent variable was continuous or 
categorical. One year survival was compared by making each 
independent variable categorical and using Chi-square test. 




Table 1 shows characteristics of the study participants, aver-
age number of medications (excluding vitamins and calcium) 
and polypharmacy for the group as a whole and divided by 
countries, gender, and age. The average number of drugs was 
6.2(SD+/- 3.7) ranging from zero to 19 drugs per person. The 
lowest number of medications was seen in Norway and it was 
significantly lower than in other countries (p<.001). Women 
tended to use more medications compared with men but this 
was a non-significant difference when looking at each coun-
try separately. Men used significantly more medications in 
Finland (p< .001). An association between age and number of 
medications was not seen but a trend was seen for an increase 
in number from age 75 to 85 and then a decline. The oldest 
group took on average the fewest medications. Polypharmacy 
(5 or more medications) was seen in 65.8% of participants. 
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• Inappropriate drugs defined as using one 
or more : drugs with high anticholinergic 
activity,benzodiazepins with long half 
lifes, cimetidine, theophyllamin or quinine
Multiple linear regression adjusted for 
the following covariates: Gender,age, 
cardiovascular drugs,psychotrophics and 
number of drugs and inappropriate drugs.
*p<.05, **p<.001
†Significant association to worse outcome.
‡Significant association to better outcome.
n.s= not significant, IADL=insturmental 
activities of daily life, ADL= Activities 
of daily life,CPS=Cognitive perfomance 
scale, LOS= length of stay.  
Table 3: Statistical testing of number of 
drugs and inappropriateo drugs among 
eldery people admitted to hospital at 
admission 
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• The multiple linear regression ad-
justed for the following covariates: 
Number of drugs, inappropriate 
drugs, cardiovascular drugs, gender 
and age
• •The multiple linear regression 
adjusted for the covariates: Number 
of drugs, inappropriate drugs, psy-
chotrophics, gender and age
*p<.05 ,**p<.001 
†Association to worse function ‡ 
Association to better function 
n.s.=not significant, 
IADL=Insturmental activities of 
daily life, ADL= Activities of daily 
life,CPS=Cognitive perfomance 
scale, LOS= length of stay.
Table 4: Statistical analyses of 
psychotrophic and cardiovascular 
drugs among elderly patients ad-
mitted to hospital at admission
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Five to 9 medications were used by 47% and 19% used 10 or 
more medications. In Norway less polypharmacy was seen 
than in other countries. 
 
Of the whole group, 15.8% used potentially inappropriate 
medications (Table 2). The majority of those used only one 
drug from the defined group and no patient used more than 
two potentially inappropriate medications. We therefore 
present these users as one group. One or more psychotrophic 
medications was used by 47.7% of the group. The most com-
mon psychotropics were hypnotic and anxiolytic drugs, 38.5%. 
Antidepressants were used by 21.5% and antipsychotics by 
5.8%. Psychotropic medication use was significantly more 
common among females than males when looking at the group 
as a whole. Age difference was not significant, except for use 
of antidepressants with the oldest group using less than others 
but the numbers were small. The most common drug group in 
the study was cardiovascular drugs, 70.8% of the participants 
took at least one drug from this category. 
 
Table 3 shows associations of number of drugs and inappropri-
ate medications with tested variables. Number of medications 
had a significant association with worse IADL function and 
prevalence of chronic pain but to fewer falls and better cogni-
tive function. The association of number of medications was 
non-significant with other studied variables and there was no 
relationship with survival at one year. The use of inappropriate 
medications had a significant association with length of stay 
which was on average seven days longer. There was no asso-
ciation of inappropriate medication with 12 months survival.
Use of psychotropic medications had a negative association 
with worse ADL, IADL, CPS, walking functions, and longer 
hospital stay. This kind of association was also seen after 
adjusting for confounding variables and in addition association 
with history of falls (Table 4). The use of cardiovascular drugs 
was shown to have an association with better functioning in 
IADL, continence, and better cognitive function. There was no 
association with survival at one year (Table 4). 
 
We did an analysis of subgroups of psychotropics and cardio-
vascular drugs (not ín Table). Antipsychotics showed a signifi-
cant association with worse function for ADL,CPS, memory, 
IADL and walking (p<0.001). Antidepressants showed as-
sociation with worse ADL, IADL and falls (p<0.001) and with 
worse CPS, memory and increased length of stay (p< 0.05). 
Hypnotics and sedatives showed association with worse ADL, 
increased length of stay and delirium (p< 0.05). 
The effect of medications on functional parameters was not 
strong in this study overall, only explaining about 2-14% of the 
variance in function and other outcome measures. 
 
Discussion 
Results of this analyses showed significant polypharmacy with 
persons 75+ years of age admitted to acute medical care and 
a high prevalence of both psychotropic and potentially inap-
propriate medication use. The association of different types 
of medications with functional variables, and length of stay, 
varied.
Polypharmacy was prevalent with 66% of participants using 
5 or more medications. The average number of drugs was 6.2. 
This is similar to other studies for this group of old hospital-
ized patients(27,28) . Even though the study material is small 
there is a striking difference in the degree of polypharmacy 
between Norwegian (38%) and the other study sites (over 
70%). This difference was also seen with specific groups like 
cardiovascular and psychotropic medications. Other studies 
have shown similar results for drug use in Norway and could 
point to differences in treatment policy in Norway compared 
with other countries. Polypharmacy was shown to have an as-
sociation with worse IADL function and more chronic pain but 
better cognitive function and less falls. These findings might 
indicate that deterioration in IADLs occur due to severity of 
an acute or underlying chronic illness and the use of multiple 
medications might be an attempt to compensate for a serious 
health situation. The association between effect of polyphar-
macy and functional impairment is of course complicated as 
the conflicting result of association with fewer falls and better 
cognitive function shows.
Women used on average more medications than men. Particu-
larly psychotropic medications which is in line with results 
from other studies.(29,30) The reason for gender difference has 
been speculated on. One of the reasons might be that women 
are more willing to seek medical care for their problems and 
accept medical treatment from physicians. Psychiatric diag-
noses are also more common among women and could partly 
explain gender difference in psychotropic drug use(31,32,33). 
 
Sixteen percent of participants took medications that fit a 
definition of potentially inappropriate drugs for old people. 
Comparing studies on frequency of inappropriate drug use 
can be difficult because of variations in definition between 
different studies(11,12,34,35,36). Inappropriate medication use 
in this study was associated with significantly longer hospital 
stay and worse IADL function as registered by the MDS-AC 
instrument.
The use of psychotropic medications in this study was quite 
high, 48%. Psychotropic drug use had, in our study, the most 
pronounced associatons with measured variables. There was 
an association with worse ADL and IADL function, CPS, 
walking function, falls and an association with longer hospital 
stay. This is consistent with other studies and psychotropic 
medications are justifiably common on lists of potentially 
inappropriate medications for older people.(15,37,38) Due to 
high risk of adverse effects use of any psychotropic medica-
tions should be carefully considered and avoided if possible in 
context of an acute illness. 
 
Cardiovascular medication use in our study was associated 
with better function, a finding that is not consistent with 
some other studies.(19,21,39) The reason for this finding is not 
obvious but could be related to prevention of stroke or other 
benefits of these medications. 
It is a strength of this study to use a standardized assessment 
instrument to register functional variables, the Inter RAI 
MDS-AC. The instrument gives an opportunity to associate 
drug treatment and outcome variables measured in a 
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standardized manner and opens the possibility of international 
comparative studies. Secondly the multicenter design is a 
strength with participation of all Nordic countries in the study, 
minimizing risk of confounding because of local factors.
There are weaknesses. The small sample size per country did 
not allow for detailed analyses at country level. Information 
was lacking on diagnosis for the current acute disease as data 
was collected so early on admission that diagnoses had not 
been made. Also, it should be kept in mind that the data was 
ten years old and the profile of medication use and differ-
ence between countries might have evolved in time. However 
results on possible association of certain drug treatments with 
functional variables registered with the MDS-AC assessment 
are of course not affected by time. In this study the average 
score on the functional scales is low and on a narrow interval. 
As an example the average score on the ADL scale was only 
0,47 on a 0 to 5 scale (0=no impairment and 5=great impair-
ment). This might actually have caused an underestimation of 
the effect of drug treatment. 
In conclusion, associations between polypharmacy, use of 
inappropriate medications and psychotropic medications and 
negative outcomes were seen and they were mostly consistent 
with current knowledge. We conclude that individual tailoring 
of the pharmacotherapy of acutely ill old patients with con-
comitant chronic illnesses combined with functional impair-
ments, is necessary. On acute somatic wards attention has to 
be paid to individualizing treatment to avoid both overtreat-
ment and undertreatment and minimize risk for ADRs. 
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